ArticleJournal of medical cases2022

The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report.

Ryan Patrick Fanning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.